Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2009

View Archived Issues

Apoptosis inducers in early development at Chinese Academy of Medical Science

AstraZeneca reports second quarter 2009 results

VAK-694 safety and tolerability to be assessed by Novartis in allergic rhinitis phase II trial

Gilead presents studies of its pharmaco-enhancer GS-9350 in the treatment of HIV

Xinchang Pharmaceutical Factory claims novel anticancer compounds

Merz discloses mGluR5 modulators for the treatment of pain

Sativex is well tolerated and improves spasticity due to multiple sclerosis in clinical trial

ACE-011 active against bone loss in postmenopausal women

TBR-652 in vitro activity in combination with antiretrovirals and human pharmacokinetics reported

Botulinum toxin type A improves various Parkinson's disease symptoms

ONO-5334 shows potential for osteoporosis therapy in ovariectomized monkeys

Cell Therapeutics reports 18-month follow-up data from phase III pixantrone study

Biovex and FDA agree on design for pivotal phase III OncoVEX(GM-CSF) study

Cytavis initiates phase II aviscumine trial in metastatic colorectal carcinoma

DNage initiates observational study in children with Cockayne syndrome

EMEA recommends orphan drug designation of intravenous CP-4126 for pancreatic cancer

European Commission approves expanded use for raltegravir in adults with HIV

FDA clears D3 FastPoint L-DFATM respiratory virus identification kit

Hyperion Therapeutics enrolls first patient in HPN-100 trial in children with urea cycle disorders

Lexicon initiates phase II trial of LX-4211 in type 2 diabetes

Poniard presents update on pivotal phase III picoplatin trial in lung cancer

FDA grants orphan drug designation to Restanza for plague and tularemia

RX-100 shows potential in protecting against lethal whole-body radiation

ZaBeCor begins phase II Excellair trial in asthma patients

Seaside Therapeutics secures funding to support studies in autism and fragile X syndrome

FDA approves Valturna, a single-pill combination of aliskiren and valsartan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...